Develops drugs for Alzheimer's and Parkinson's diseases.
Dec 2025Revenue $0.00/yrExpenses $29.7M/yr
No trendCash runway ≈ 5 months from Jun 2026
Figures by year
When will Annovis Bio be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $0.00 and expenses $29.7M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $0.00 | $29.7M | −$29.7M |
| Dec 2024 | $0.00 | $26.7M | −$26.7M |
| Dec 2023 | $0.00 | $45.0M | −$45.0M |
| Dec 2022 | $0.00 | $25.5M | −$25.5M |
| Dec 2021 | $0.00 | $14.5M | −$14.5M |
| Dec 2020 | $0.00 | $6.64M | −$6.64M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.